PROVIDENCE, R.I., 27. Februar 2025 /PRNewswire/ — EpiVax, Inc. gibt mit Stolz die Ernennung von Guilhem Richard zum leitenden Technologievorstand bekannt. Dr. Richard kam 2014 zum Immuninformatik-Team von EpiVax und leitete die Entwicklung einer neuen Rechenplattform für die Entwicklung…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.